Highlights
A collection of news and information related to Novartis AG published by this site and its partners.
Displaying items 1-12 of 110
» View latimes.com items only
1
2
3
4
5
6
7
8
9
10
•
Next >
-
Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle
Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...
Tags: Lymphoma, National Basketball Association, Jimmy Kimmel, Jimmy Kimmel Live! (tv program), Los Angeles Lakers
-
Indian court ruling hailed as victory for generic drugs
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: U.S. Chamber of Commerce, Patents, Copyrights and Trademarks, Economic Organization, Trade Agreements, Trade Dispute
-
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: Science and Technology, Crime, Law and Justice, Chemical Industry, Patents, Copyrights and Trademarks, Pharmaceuticals
-
An insider's view of generic-drug pricing
Bob Toomajian worked for 16 years as Kaiser Permanente's drug purchasing manager for Southern California, giving him an insider's knowledge of how medications are priced before reaching consumers. When it comes to patented name-brand drugs, he told me,...
Tags: Teva Pharmaceutical Industries Limited, Chemical Industry, High Blood Pressure, Diovan (drug), Target
-
Swiss voters say yes to 'Rip-Off Initiative' to control executive pay
Voters in Switzerland, angered by high executive pay, backed a plan to increase the control of shareholders over compensation of corporate leaders. Nearly 70% of voters approved the so-called "Rip-Off Initiative," according to the Swiss television...
Tags: Chemical Industry, Television Industry, Politics, CEO Pay, Television Stations
-
Corporations and execs need penalties that hurt
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
Tags: Schering Plough Corporation, Michael Mukasey, Crime, Law and Justice, BP Plc, Countrywide Financial Corp.
-
Novartis patent case in India seen as crucial for generic drugs
World NowThe Indian Supreme Court is slated Wednesday to take up a case that aid agencies warn could have sweeping effects on medicine for the global poor, the culmination of a lengthy legal battle between a Swiss drug company and a country known as a mecca for... -
Greek leader pleads for more time to implement reforms
World NowGreek Prime Minister Antonis Samaras launched a high-gear diplomatic offensive aimed at buying his country more time to implement reforms demanded by increasingly impatient European creditors.... -
Fighting diseases with genetic therapy
Genes make us who we are — in sickness and in health. We get our genetic makeup from our parents, of course, but in the future, we might be getting genes from our doctors too. Imagine your doctor promising to cure your cancer or heart disease by...
Tags: Philadelphia (Philadelphia, Pennsylvania), University of Washington, Physical Conditions, Oncology, HIV
-
FDA approves first oral drug to slow multiple sclerosis progression
A failed anti-rejection drug got a new purpose and a new lease on commercial life Wednesday as the Food and Drug Administration approved the medication fingolimod -- to be marketed as Gilenya -- to slow the progression of disability in multiple...Tags: Crime, Law and Justice, Trials, National Institutes of Health, Multiple Sclerosis, Television
-
We want drama! ABC soap fans rally to keep Erica Kane and her daytime friends on the air
Show TrackerLike sands through the hourglass, daytime soap operas are falling off the TV grid. The recent demise started in 2007 with the cancellation of “Passions” on NBC (and later on DirecTV). Two years later, CBS nixed “The Guiding Light”... -
Blood pressure drugs need to match the situation
For some people, lifestyle measures are enough to keep blood pressure under control. But they're not enough for everyone.
For one thing, "many patients are not willing to change their lifestyle," says Dr. Peter Rudd, professor of medicine emeritus at the...Tags: Crime, Law and Justice, High Blood Pressure, Heart Failure, Education, Stanford University
Apr 12, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Los Angeles Times
Mar 31, 2013
|Story| Los Angeles Times
Mar 25, 2013
|Column| Los Angeles Times
Mar 4, 2013
|Story| Los Angeles Times
Jan 5, 2013
|Column| Los Angeles Times
Aug 22, 2012
| Los Angeles Times
Aug 22, 2012
| Los Angeles Times
Sep 13, 2012
|Story| Los Angeles Times
Sep 22, 2010
|Story| Los Angeles Times
Apr 21, 2011
| Los Angeles Times
Feb 8, 2010
|Story| Los Angeles Times
